Point72 Asset Management’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Buy |
+914,190
| New | +$1.13M | ﹤0.01% | 942 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1672 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1632 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1633 |
|
|
2024
Q1 | – | Sell |
-5,349,146
| Closed | -$52.5M | – | 1768 |
|
|
2023
Q4 | $52.5M | Buy |
5,349,146
+2,755,364
| +106% | +$27M | 0.13% | 194 |
|
|
2023
Q3 | $21.7M | Sell |
2,593,782
-4,067,851
| -61% | -$34M | 0.06% | 355 |
|
|
2023
Q2 | $88.6M | Sell |
6,661,633
-627,735
| -9% | -$8.35M | 0.26% | 84 |
|
|
2023
Q1 | $84.4M | Buy |
7,289,368
+1,957,373
| +37% | +$22.7M | 0.26% | 85 |
|
|
2022
Q4 | $43.6M | Buy |
5,331,995
+2,797,889
| +110% | +$22.9M | 0.15% | 174 |
|
|
2022
Q3 | $14.7M | Buy |
+2,534,106
| New | +$14.7M | 0.06% | 379 |
|
|
2021
Q1 | – | Sell |
-40,000
| Closed | -$1.04M | – | 1069 |
|
|
2020
Q4 | $1.04M | Sell |
40,000
-2,271,631
| -98% | -$58.9M | 0.01% | 759 |
|
|
2020
Q3 | $22.8M | Buy |
+2,311,631
| New | +$22.8M | 0.12% | 231 |
|
|
2018
Q4 | – | Sell |
-5,175,000
| Closed | -$28M | – | 1016 |
|
|
2018
Q3 | $28M | Buy |
5,175,000
+2,275,000
| +78% | +$12.3M | 0.12% | 173 |
|
|
2018
Q2 | $10.3M | Buy |
2,900,000
+800,000
| +38% | +$2.84M | 0.04% | 346 |
|
|
2018
Q1 | $4.31M | Buy |
+2,100,000
| New | +$4.31M | 0.02% | 489 |
|
|
2017
Q2 | – | Sell |
-1,279,200
| Closed | -$6.61M | – | 836 |
|
|
2017
Q1 | $6.61M | Buy |
+1,279,200
| New | +$6.61M | 0.04% | 438 |
|
|
2016
Q2 | – | Sell |
-706,500
| Closed | -$6.01M | – | 762 |
|
|
2016
Q1 | $6.01M | Buy |
706,500
+700,300
| +11,295% | +$5.95M | 0.05% | 364 |
|
|
2015
Q4 | $81K | Sell |
6,200
-10,900
| -64% | -$142K | ﹤0.01% | 608 |
|
|
2015
Q3 | $63K | Buy |
17,100
+17,000
| +17,000% | +$62.6K | ﹤0.01% | 658 |
|
|
2015
Q2 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 650 |
|